Hydroxyethylstarch in cryopreservation - Mechanisms, benefits and problems

Transfusion and Apheresis Science

Volumn 46, Issue 2, 2012, Pages 137-147

  Stolzing, A ^a   Naaldijk, Y ^a   Fedorova, V ^a   Sethe, S ^b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cryopreservation; Dimethysulfoxide; Hydroxyethyl starch; Stem cells

Indexed keywords

CRYOPROTECTIVE AGENT; DIMETHYL SULFOXIDE; HETASTARCH; ICE;

APOPTOSIS; CELL DEATH; CELL SURVIVAL; CHEMICAL STRUCTURE; CRYOPRESERVATION; CRYOPROTECTION; CRYSTALLIZATION; ERYTHROCYTE; FREEZING; HEMATOPOIETIC STEM CELL; HUMAN; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PROCESS OPTIMIZATION; REVIEW;

CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; HETASTARCH; HUMANS; PLASMA SUBSTITUTES; STEM CELLS;

EID: 84858299137     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.01.007     Document Type: Review

References (116)

1. Fowler A., Toner M. Cryo-injury and biopreservation. Ann N Y Acad Sci 2005, 1066:119-135.
2. Muller K., Muller P., Pincemy G., Kurz A., Labbe C. Characterization of sperm plasma membrane properties after cholesterol modification: consequences for cryopreservation of rainbow trout spermatozoa. Biol Reprod 2008, 78(3):390-399.
3. Gage A.A., Baust J.G. Cryosurgery - a review of recent advances and current issues. Cryo Lett 2002, 23(2):69-78.
4. Mazur P. Cryobiology: the freezing of biological systems. Science 1970, 168(934):939-949.
5. Mishima O., Suzuki Y. Propagation of the polyamorphic transition of ice and the liquid-liquid critical point. Nature 2002, 419(6907):599-603.
6. Diller K.R., Aggarwal S.J. Computer automated cell size and shape analysis in cryomicroscopy. J Microsc 1987, 146(Pt 2):209-219.
7. Taylor M.J., Pegg D.E. The effect of ice formation on the function of smooth muscle tissue stored at -21 or -60°C. Cryobiology 1983, 20(1):36-40.
8. Irimia D., Karlsson J.O. Kinetics and mechanism of intercellular ice propagation in a micropatterned tissue construct. Biophys J 2002, 82(4):1858-1868.
9. Karlsson J.O., Toner M. Long-term storage of tissues by cryopreservation: critical issues. Biomaterials 1996, 17(3):243-256.
10. Muldrew K., McGann L.E. The osmotic rupture hypothesis of intracellular freezing injury. Biophys J 1994, 66(2 Pt 1):532-541.
11. Baust J.M., Van B., Baust J.G. Cell viability improves following inhibition of cryopreservation-induced apoptosis. In Vitro Cell Dev Biol Anim 2000, 36(4):262-270.
12. Jeong Y.J., Kim M.K., Song H.J., Kang E.J., Ock S.A., Kumar B.M., et al. Effect of alpha-tocopherol supplementation during boar semen cryopreservation on sperm characteristics and expression of apoptosis related genes. Cryobiology 2009, 58(2):181-189.
13. Mazzilli F., Rossi T., Sabatini L., Pulcinelli F.M., Rapone S., Dondero F., et al. Human sperm cryopreservation and reactive oxygen species (ROS) production. Acta Eur Fertil 1995, 26(4):145-148.
14. Tselkas K., Saratsis P., Karagianidis A., Samouilidis S. Extracellular presence of reactive oxygen species (ROS) in fresh and frozen-thawed canine semen and their effects on some semen parameters. Dtsch Tierarztl Wochenschr 2000, 107(2):69-72.
15. Sohn I.P., Ahn H.J., Park D.W., Gye M.C., Jo D.H., Kim S.Y., et al. Amelioration of mitochondrial dysfunction and apoptosis of two-cell mouse embryos after freezing and thawing by the high frequency liquid nitrogen infusion. Mol Cell 2002, 13(2):272-280.
16. Thomson L.K., Fleming S.D., Aitken R.J., De Iuliis G.N., Zieschang J.A., Clark A.M. Cryopreservation-induced human sperm DNA damage is predominantly mediated by oxidative stress rather than apoptosis. Hum Reprod 2009, 24(9):2061-2070.
17. Alvarez J.G., Storey B.T. Evidence for increased lipid peroxidative damage and loss of superoxide dismutase activity as a mode of sublethal cryodamage to human sperm during cryopreservation. J Androl 1992, 13(3):232-241.
18. McAnulty J.F., Huang X.Q. The efficacy of antioxidants administered during low temperature storage of warm ischemic kidney tissue slices. Cryobiology 1997, 34(4):406-415.
19. Stevenson D.J., Morgan C., McLellan L.I., Helen Grant M. Reduced glutathione levels and expression of the enzymes of glutathione synthesis in cryopreserved hepatocyte monolayer cultures. Toxicol In Vitro 2007, 21(3):527-532.
20. Bilodeau J.F., Chatterjee S., Sirard M.A., Gagnon C. Levels of antioxidant defenses are decreased in bovine spermatozoa after a cycle of freezing and thawing. Mol Reprod Dev 2000, 55(3):282-288.
21. Honda S., Weigel A., Hjelmeland L.M., Handa J.T. Induction of telomere shortening and replicative senescence by cryopreservation. Biochem Biophys Res Commun 2001, 282(2):493-498.
22. Cabrita E., Robles V., Rebordinos L., Sarasquete C., Herraez M.P. Evaluation of DNA damage in rainbow trout (Oncorhynchus mykiss) and gilthead sea bream (Sparus aurata) cryopreserved sperm. Cryobiology 2005, 50(2):144-153.
23. Duthie S.J., Pirie L., Jenkinson A.M., Narayanan S. Cryopreserved versus freshly isolated lymphocytes in human biomonitoring: endogenous and induced DNA damage, antioxidant status and repair capability. Mutagenesis 2002, 17(3):211-214.
24. Peng L., Wang S., Yin S., Li C., Li Z., Liu Q. Autophosphorylation of H2AX in a cell-specific frozen dependent way. Cryobiology 2008, 57(2):175-177.
25. Vandevoort C.A., Shirley C.R., Hill D.L., Leibo S.P. Effects of cryoprotectants and cryopreservation on germinal vesicle-stage cumulus-oocyte complexes of rhesus monkeys. Fertil Steril 2008, 90(3):805-816.
26. McGann L.E. Differing actions of penetrating and nonpenetrating cryoprotective agents. Cryobiology 1978, 15(4):382-390.
27. Lehle K., Hoenicka M., Jacobs V.R., Schmid F.X., Birnbaum D.E. Cryopreservation of human endothelial cells for vascular tissue engineering. Cryobiology 2005, 50(2):154-161.
28. Takahashi T., Hirsh A., Erbe E., Williams R.J. Mechanism of cryoprotection by extracellular polymeric solutes. Biophys J 1988, 54(3):509-518.
29. Bakaltcheva I., Ganong J.P., Holtz B.L., Peat R.A., Reid T. Effects of high-molecular-weight cryoprotectants on platelets and the coagulation system. Cryobiology 2000, 40(4):283-293.
30. Chao H., Davies P.L., Carpenter J.F. Effects of antifreeze proteins on red blood cell survival during cryopreservation. J Exp Biol 1996, 199(Pt 9):2071-2076.
31. Thompson W.L., Fukushima T., Rutherford R.B., Walton R.P. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch. Surg Gynecol Obstet 1970, 131(5):965-972.
32. Jurecka W., Szepfalusi Z., Parth E., Schimetta W., Gebhart W., Scheiner O., et al. Hydroxyethylstarch deposits in human skin - a model for pruritus?. Arch Dermatol Res 1993, 285(1-2):13-19.
33. Dienes H.P., Gerharz C.D., Wagner R., Weber M., John H.D. Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension. J Hepatol 1986, 3(2):223-227.
34. Stander S., Szepfalusi Z., Bohle B., Stander H., Kraft D., Luger T.A., et al. Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study. Cell Tissue Res 2001, 304(2):261-269.
35. Nohe B., Burchard M., Zanke C., Eichner M., Krump-Konvalinkova V., Kirkpatrick C.J., et al. Endothelial accumulation of hydroxyethyl starch and functional consequences on leukocyte-endothelial interactions. Eur Surg Res 2002, 34(5):364-372.
36. Fernandez O., Bethencourt L., Quero A., Sangwan R.S., Clement C. Trehalose and plant stress responses: friend or foe?. Trends Plant Sci 2010, 15(7):409-417.
37. Storey K.B. Life in a frozen state: adaptive strategies for natural freeze tolerance in amphibians and reptiles. Am J Physiol 1990, 258(3 Pt 2):R559-R568.
38. Crowe J.H., Crowe L.M., Chapman D. Preservation of membranes in anhydrobiotic organisms: the role of trehalose. Science 1984, 223(4637):701-703.
39. Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg 2009, 108(5):1574-1582.
40. Kozek-Langenecker S.A. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005, 103(3):654-660.
41. Treib J., Baron J.F., Grauer M.T., Strauss R.G. An international view of hydroxyethyl starches. Intensive Care Med 1999, 25(3):258-268.
42. Treib J., Haass A., Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997, 78(3):974-983.
43. Sputtek A. HES - A Nightmare? Society for Low Temperature Biology (SLTB) Newsletter February. 2001 Available from: http://www.sputtek.de/info/HES.pdf.
44. Korber C., Scheiwe M.W. The cryoprotective properties of hydroxyethyl starch investigated by means of differential thermal analysis. Cryobiology 1980, 17(1):54-65.
45. Connor W., Ashwood-Smith M.J. Cryoprotection of mammalian cells in tissue culture with polymers; possible mechanisms. Cryobiology 1973, 10(6):488-496.
46. Thomas M.J., Parry E.S., Nash S.G., Bell S.H. A method for the cryopreservation of red blood cells using hydroxyethyl starch as a cryoprotectant. Transfus Sci 1996, 17(3):385-396.
47. Baust J.G., Gage A.A., Klossner D., Clarke D., Miller R., Cohen J., et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat 2007, 6(2):97-109.
48. Ziese W. Action of amylascs on hydroxyethyl starch. Z Physiol Chem 1934, 229:213.
49. Wiedersheim M. Synthetic macromolecular compounds and their use in medical therapy. S Afr J Lab Clin Med 1957, 3(2):118-130.
50. Roy A.J., Franklin A., Simmons W.B., Djerassi I. A method for separation of granulocytes from normal human blood using hydroxyethyl starch. Prep Biochem 1971, 1(3):197-203.
51. Ballinger W.F., Solanke T.F., Thompson W.L. The effect of hydroxyethyl starch upon survival of dogs subjected to hemorrhagic shock. Surg Gynecol Obstet 1966, 122(1):33-36.
52. Gollub S., Schechter D.C., Hirose T., Bailey C.P. Use of hydroxyethyl starch solution in extensive surgical operations. Surg Gynecol Obstet 1969, 128(4):725-728.
53. Garzon A.A., Cheng C., Lerner B., Lichtenstein S., Karlson K.E. Hydroxyethyl starch (HES) and bleeding. An experimental investigation of its effect on hemostasis. J Trauma 1967, 7(5):757-766.
54. Knorpp C.T., Merchant W.R., Gikas P.W., Spencer H.H., Thompson N.W. Hydroxyethyl starch: extracellular cryophylactic agent for erythrocytes. Science 1967, 157(794):1312-1313.
55. Lovelock J.E., Bishop M.W. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 1959, 183(4672):1394-1395.
56. Persidsky M.D., Ellett M.H. Hydroxyethyl starch as a cryopreservative for nucleated mammalian cells. Cryobiology 1971, 8(6):586-588.
57. Ashwood-Smith M.J., Warby C., Connor K.W., Becker G. Low-temperature preservation of mammalian cells in tissue culture with polyvinylpyrrolidone (PVP), dextrans, and hydroxyethyl starch (HES). Cryobiology 1972, 9(5):441-449.
58. Lionetti F.J., Hunt S.M. Cryopreservation of human red cells in liquid nitrogen with hydroxyethyl starch. Cryobiology 1975, 12(2):110-118.
59. Lionetti F.J., Hunt S.M., Mattaliano R.J., Valeri C.R. In vitro studies of cryopreserved baboon granulocytes. Transfusion 1978, 18(6):685-692.
60. Stiff P.J., Murgo A.J., Zaroulis C.G., DeRisi M.F., Clarkson B.D. Unfractionated human marrow cell cryopreservation using dimethylsulfoxide and hydroxyethyl starch. Cryobiology 1983, 20(1):17-24.
61. Stiff P.J., Koester A.R., Weidner M.K., Dvorak K., Fisher R.I. Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing. Blood 1987, 70(4):974-978.
62. Kim H., Tanaka S., Une S., Nakaichi M., Sumida S., Taura Y. A comparative study of the effects of glycerol and hydroxyethyl starch in canine red blood cell cryopreservation. J Vet Med Sci 2004, 66(12):1543-1547.
63. Lionetti F.J., Hunt S.M., Gore J.M., Curby W.A. Cryopreservation of human granulocytes. Cryobiology 1975, 12(3):181-191.
64. Kenmochi T., Asano T., Maruyama M., Saigo K., Akutsu N., Iwashita C., et al. Cryopreservation of human pancreatic islets from non-heart-beating donors using hydroxyethyl starch and dimethyl sulfoxide as cryoprotectants. Cell Transplant 2008, 17(1-2):61-67.
65. Maruyama M., Kenmochi T., Sakamoto K., Arita S., Iwashita C., Kashiwabara H. Simplified method for cryopreservation of islets using hydroxyethyl starch and dimethyl sulfoxide as cryoprotectants. Transplant Proc 2004, 36(4):1133-1134.
66. Luo K., Wu G., Wang Q., Sun Y., Liu H. Effect of dimethylsulfoxide and hydroxyethyl starch in the preservation of fractionated human marrow cells. Cryobiology 1994, 31(4):349-354.
67. Sudo K., Asoh S., Ohsawa I., Ozaki D., Yamagata K., Ito H., et al. The anti-cell death FNK protein protects cells from death induced by freezing and thawing. Biochem Biophys Res Commun 2005, 330(3):850-856.
68. Neveux N., De Bandt J.P., Charrueau C., Savier E., Chaumeil J.C., Hannoun L., et al. Deletion of hydroxyethylstarch from University of Wisconsin solution induces cell shrinkage and proteolysis during and after cold storage of rat liver. Hepatology 1997, 25(3):678-682.
69. Mabrut J.Y., Adham M., Bourgeot J.P., Eljaafari A., DelaRoche E., Ducerf C., et al. Mechanical and histological characteristics of human trachea before and after cryopreservation: an opportunity for tracheal tissue banking. Transplant Proc 2001, 33(1-2):609-611.
70. Sputtek A., Horn E.P., Schulte Am Esch J., Kuhnl P. Cryopreservation of red blood cells using hydroxyethyl starch (HES) - from laboratory investigations to clinical application. Anasthesiol Intensivmed Notfallmed Schmerzther 2001, 36(Suppl 2):S162-S164.
71. Allen E.D., Weatherbee L., Permoad P.A. Post-thaw suspension of red cells cryopreserved with hydroxyethyl starch. Cryobiology 1978, 15(4):375-381.
72. Arakawa T., Bhat R., Timasheff S.N. Why preferential hydration does not always stabilize the native structure of globular proteins. Biochemistry 1990, 29(7):1924-1931.
73. Gurtovenko A.A., Anwar J. Modulating the structure and properties of cell membranes: the molecular mechanism of action of dimethyl sulfoxide. J Phys Chem B 2007, 111(35):10453-10460.
74. Zambelli A., Poggi G., Da Prada G., Pedrazzoli P., Cuomo A., Miotti D., et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998, 18(6B):4705-4708.
75. Ferrucci P.F., Martinoni A., Cocorocchio E., Civelli M., Cinieri S., Cardinale D., et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000, 25(2):173-177.
76. Stroncek D.F., Strand R.D., Hofkes C.L., McCullough J. Comparison of the effectiveness of potential marrow donors recruited from apheresis donors or whole blood donors and through appeals to the general public. Transfusion 1991, 31(2):138-141.
77. Rowley S.D., Feng Z., Yadock D., Holmberg L., Macleod B., Heimfeld S. Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade. Cytotherapy 1999, 1(6):439-446.
78. Chen-Plotkin A.S., Vossel K.A., Samuels M.A., Chen M.H. Encephalopathy, stroke, and myocardial infarction with DMSO use in stem cell transplantation. Neurology 2007, 68(11):859-861.
79. Scheinkonig C., Kappicht S., Kolb H.J., Schleuning M. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Bone Marrow Transplant 2004, 34(6):531-536.
80. Antonenas V., Shaw P.J., Bradstock K.F. Infusion of unwashed umbilical cord blood stem cells after thawing for allogeneic transplantation. Bone Marrow Transplant 2004, 34(8):739.
81. Perotti C.G., Del Fante C., Viarengo G., Papa P., Rocchi L., Bergamaschi P., et al. A new automated cell washer device for thawed cord blood units. Transfusion 2004, 44(6):900-906.
82. Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M., Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000, 96(8):2717-2722.
83. Gluckman E., Rocha V., Chevret S. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2001, 5(2):87-99.
84. Windrum P., Morris T.C., Drake M.B., Niederwieser D., Ruutu T. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplant 2005, 36(7):601-603.
85. Brecher M.E., Owen H.G., Bandarenko N. Alternatives to albumin: starch replacement for plasma exchange. J Clin Apher 1997, 12(3):146-153.
86. Rowley S.D., Feng Z., Chen L., Holmberg L., Heimfeld S., MacLeod B., et al. A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch. Bone Marrow Transplant 2003, 31(11):1043-1051.
87. Neff T.A., Fischler L., Mark M., Stocker R., Reinhart W.H. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005, 100(6):1773-1780.
88. Westphal M., James M.F., Kozek-Langenecker S., Stocker R., Guidet B., Van Aken H. Hydroxyethyl starches: different products - different effects. Anesthesiology 2009, 111(1):187-202.
89. Hulse J.D., Yacobi A. Hetastarch: an overview of the colloid and its metabolism. Drug Intell Clin Pharm 1983, 17(5):334-341.
90. Kohler H., Zschiedrich H., Clasen R., Linfante A., Gamm H. The effects of 500ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure and renal function in human volunteers (author's transl). Der Anaesthesist 1982, 31(2):61-67.
91. Treib J., Haass A., Pindur G., Grauer M.T., Jung F., Wenzel E., et al. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch. Arzneimittel-Forschung 1997, 47(1):18-22.
92. Legendre C., Thervet E., Page B., Percheron A., Noel L.H., Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993, 342(8865):248-249.
93. Dart A.B., Mutter T.C., Ruth C.A., Taback S.P. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010, (1). Article no. CD007594.
94. Sirtl C., Laubenthal H., Zumtobel V., Kraft D., Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 1999, 82(4):510-515.
95. Szepfalusi Z., Parth E., Jurecka W., Luger T.A., Kraft D. Human monocytes and keratinocytes in culture ingest hydroxyethylstarch. Arch Dermatol Res 1993, 285(3):144-150.
96. Parker N.E., Porter J.B., Williams H.J., Leftley N. Pruritus after administration of hetastarch. Br Med J (Clin Res Ed) 1982, 284(6313):385-386.
97. Laxenaire M.C., Charpentier C., Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 1994, 13(3):301-310.
98. Boldt J., Zickmann B., Rapin J., Hammermann H., Dapper F., Hempelmann G. Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand 1994, 38(5):432-438.
99. Sputtek A., Singbartl G., Langer R., Schleinzer W., Henrich H.A., Kuhnl P. Cryopreservation of erythrocytes using hydroxyethyl starch: in vivo results of an autologous retransfusion model in humans. Beitr Infusionsther Transfusionsmed 1994, 32:44-47.
100. Kim H., Itamoto K., Une S., Nakaichi M., Taura Y., Sumida S. Application of phosphoenolpyruvate into canine red blood cell cryopreservation with hydroxyethyl starch. Cryo Lett 2005, 26(1):1-6.
101. Hibino N., Shin'oka T., Matsumura G., Watanabe M., Toyama S., Imai Y. Cryopreservation of vascular mixed cell for tissue engineering in cardiovascular surgery. Kyobu Geka 2001, 54(6):479-484.
102. Pasch J., Schiefer A., Heschel I., Dimoudis N., Rau G. Variation of the HES concentration for the cryopreservation of keratinocytes in suspensions and in monolayers. Cryobiology 2000, 41(2):89-96.
103. Singbartl K., Langer R., Henrich H.A. Altered membrane skeleton of hydroxyethylstarch-cryopreserved human erythrocytes. Cryobiology 1998, 36(2):115-123.
104. Mantzavinos D., Bailey A.I., Rampling M.W. Flash freezing of erythrocyte suspensions. Biorheology 1997, 34(1):73-83.
105. Kang E.M., Areman E.M., David-Ocampo V., Fitzhugh C., Link M.E., Read E.J., et al. Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait. Blood 2002, 99(3):850-855.
106. Hayakawa J., Joyal E.G., Gildner J.F., Washington K.N., Phang O.A., Uchida N., et al. 5% Dimethyl sulfoxide (DMSO) and pentastarch improves cryopreservation of cord blood cells over 10% DMSO. Transfusion 2010, 50(10):2158-2166.
107. McCullough J., Haley R., Clay M., Hubel A., Lindgren B., Moroff G. Long-term storage of peripheral blood stem cells frozen and stored with a conventional liquid nitrogen technique compared with cells frozen and stored in a mechanical freezer. Transfusion 2010, 50(4):808-819.
108. Ide K., Matsuura S., Fujino Y., Ohno K., Tsujimoto H. Investigation of various methods for the cryopreservation of canine bone marrow-derived CD34(+) cells. J Vet Med Sci 2008, 70(11):1211-1217.
109. Halle P., Tournilhac O., Knopinska-Posluszny W., Kanold J., Gembara P., Boiret N., et al. Uncontrolled-rate freezing and storage at -80°C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001, 41(5):667-673.
110. Ayello J., Semidei-Pomales M., Preti R., Hesdorffer C., Reiss R.F. Effects of long-term storage at -90°C of bone marrow and PBPC on cell recovery, viability, and clonogenic potential. J Hematother 1998, 7(4):385-390.
111. Katayama Y., Yano T., Bessho A., Deguchi S., Sunami K., Mahmut N., et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 1997, 19(3):283-287.
112. Donaldson C., Armitage W.J., DenningKendall P.A., Nicol A.J., Bradley B.A., Hows J.M. Optimal cryopreservation of human umbilical cord blood. Bone Marrow Transplant 1996, 18(4):725-731.
113. Takaue Y., Abe T., Kawano Y., Suzue T., Saito S., Hirao A., et al. Comparative-analysis of engraftment after cryopreservation of peripheral-blood stem-cell autografts by controlled-rate versus uncontrolled-rate methods. Bone Marrow Transplant 1994, 13(6):801-804.
114. Clapisson G., Salinas C., Malacher P., Michallet M., Philip I., Philip T. Cryopreservation with hydroxyethylstarch (HES) + dimethylsulfoxide (DMSO) gives better results than DMSO alone. Bull Cancer 2004, 91(4):E97-E102.
115. Lippens E., Cornelissen M. Slow cooling cryopreservation of cell-microcarrier constructs. Cells Tissues Organs 2010, 192(3):177-186.
116. Kawasaki N., Hamamoto Y., Nakajima T., Irie K., Ozawa H. Periodontal regeneration of transplanted rat molars after cryopreservation. Arch Oral Biol 2004, 49(1):59-69.